Mepromax Life Sciences Private Limited - Company Profile

It is a pharma private limited company based in Wadhwan, Gujarat, India, established in 2005.
2005 Wadhwan, Gujarat, India Active
Last Updated:
Access Report
About Mepromax Life Sciences Private Limited

Mepromax Life Sciences Private Limited, a active private limited company, was established on 21 April 2005 in Wadhwan, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ2005PTC045918. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.50 M.

It upholds a compliant status. Employing 70 professional, Its leadership includes Prakash Navinchandra Shah (Whole-Time Director), Bharatkumar Chabildas Shah (Whole-Time Director), Suresh Chhabildas Shah (Whole-Time Director). Past directors included Anilkumar Rasiklal Patel, Prakash Navinchandra Shah, Bharatkumar Chabildas Shah. It holds ₹6.37 Cr open charges and ₹12.30 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Gidc Residential Plot No. H/78, Wadhwan, Gujarat, 363035.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ2005PTC045918

  • Registration Number

    045918

  • Incorporation Date

    21 April 2005

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹8.50 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 8.50 M
  • Company Age 20 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 6.37 Cr
  • Satisfied Charges ₹ 12.30 Cr
  • Revenue Growth **** 15.67%
  • Profit Growth **** 219.76%
  • Ebitda **** 119.56%
  • Net Worth 15.83%
  • Total Assets **** 10.13%
Company report

Mepromax Life Sciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mepromax Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mepromax Life Sciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Prakash Navinchandra Shah Whole-Time Director 15 Jun 2006 Current
Bharatkumar Chabildas Shah Whole-Time Director 15 Jun 2006 Current
Suresh Chhabildas Shah Whole-Time Director 15 Jun 2006 Current
Rajesh Sumanlal Shah Whole-Time Director 15 Jun 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Mar 2013 Past
Pramod Abcsdd Director 20 Jan 2015 Past
Pramod Abcsdd Director 20 Jan 2015 Past
Pramod Abcsdd Director 20 Jan 2015 Past
Pramod Abcsdd Director 17 Sep 2007 Past
Pramod Abcsdd Director 20 Jan 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mepromax Life Sciences.

Mepromax Life Sciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 15.67% increase. The company also saw a substantial improvement in profitability, with a 219.76% increase in profit. The company's net worth Soared by an impressive increase of 15.83%.

Mepromax Life Sciences revenue growth over time
Mepromax Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 15.67%
*******
*******
*******
*******
Revenue from Operations
*******
 12.82%
*******
*******
*******
*******
Total Assets
*******
 10.13%
*******
*******
*******
*******
Profit or Loss
*******
 219.76%
*******
*******
*******
*******
Net Worth
*******
 15.83%
*******
*******
*******
*******
EBITDA
*******
 119.56%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mepromax Life Sciences?

In 2024, Mepromax Life Sciences had a promoter holding of 48.33% and a public holding of 51.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹63,680,000.00

Satisfied Charges

₹123,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 6.37 Cr
Latest Charge Details
Date Lender Amount Status
14 Sep 2007 Others ₹6.37 Cr Open
19 Jan 2007 Icici Bank Limited ₹6.15 Cr Satisfied
31 Jul 2006 Icici Bank Limited ₹6.15 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Mepromax Life Sciences?

Mepromax Life Sciences has a workforce of 70 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mepromax Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mepromax Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mepromax Life Sciences
Recent Activity within the Organization
  • Annual General Meeting

    The activity Mepromax Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Mepromax Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Charges

    Progress on A charge with Others of Rs. 6.37 Cr registered on 14 Sep 2007 with Charge ID 10074912 was modified on 21 Aug 2017. was documented.

  • Charges

    The activity A charge registered on 19 Jan 2007 via Charge ID 10060904 with Icici Bank Limited was fully satisfied on 21 Jun 2012. was completed.

  • Charges

    A charge registered on 31 Jul 2006 via Charge ID 10031789 with Icici Bank Limited was fully satisfied on 21 Jun 2012. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 6.37 Cr with Charge ID 10074912 was registered on 14 Sep 2007. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mepromax Life Sciences Private Limited?

The CIN of Mepromax Life Sciences Private Limited is U24231GJ2005PTC045918.

Where is Mepromax Life Sciences Private Limited headquartered?

Mepromax Life Sciences Private Limited is headquartered at Gidc Residential Plot No. H/78, Wadhwan, Gujarat, 363035.

When was Mepromax Life Sciences Private Limited incorporated?

Mepromax Life Sciences Private Limited was incorporated on 21 April 2005.

Who are the current directors of Mepromax Life Sciences Private Limited?

The current directors of Mepromax Life Sciences Private Limited are

What is the primary industry of Mepromax Life Sciences Private Limited?

The primary industry of Mepromax Life Sciences Private Limited is Manufacturing.

Is Mepromax Life Sciences Private Limited a listed company?

Mepromax Life Sciences Private Limited is unlisted.

What is the capital structure of Mepromax Life Sciences Private Limited?

The authorized capital of Mepromax Life Sciences Private Limited is ₹1.00 Cr, and the paid-up capital is ₹8.50 M.

What is the compliance status of Mepromax Life Sciences Private Limited?

The compliance status of Mepromax Life Sciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available